VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Tempest Therapeutics, Inc. (TPST) Total Return Calculator with Dividends Reinvested

Tempest Therapeutics, Inc.

Popular:

The total return for Tempest Therapeutics, Inc. (TPST) stock is -69.72% over the past 12 months. So far it's down 31.53% this year. The 5-year total return is -87.87%, meaning $10,000 invested in TPST stock 5 years ago would be worth $1,213 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in TPST 1 year ago, it would be worth $3,146 today — you'd have lost $6,854.

With Dividends Reinvested$3,146-68.54%

Price Only (No DRIP)$3,146-68.54%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in TPST

1Y$3,028-$6,972 (-69.7%)-69.7% CAGR

3Y$758-$9,242 (-92.4%)-57.7% CAGR

5Y$1,213-$8,787 (-87.9%)-34.4% CAGR

10Y$15-$9,985 (-99.9%)-47.9% CAGR

15Y$12-$9,988 (-99.9%)-36.1% CAGR

20Y$12-$9,988 (-99.9%)-28.6% CAGR

30Y$12-$9,988 (-99.9%)-20.1% CAGR

Tempest Therapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading TPST total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-31.53%	—	-31.53%	—	$6,847
1Y	-69.72%	-69.72%	-69.72%	—	$3,028
3Y	-92.42%	-57.68%	-92.42%	—	$758
5Y	-87.87%	-34.42%	-87.87%	—	$1,213
10Y	-99.85%	-47.92%	-99.85%	—	$15
15Y	-99.88%	-36.14%	-99.88%	—	$12
20Y	-99.88%	-28.57%	-99.88%	—	$12
30Y	-99.88%	-20.09%	-99.88%	—	$12

Risk & Highlights

Best Year+385.40%2014

Worst Year-83.44%2016

Max Drawdown-87.15%2025-10-14 → 2026-03-30

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-22.71%	-22.71%	—	+0.41%	-23.1pp
2025	-74.28%	-74.28%	—	+16.64%	-90.9pp
2024	+146.03%	+146.03%	—	+24.00%	+122.0pp
2023	-72.48%	-72.48%	—	+24.81%	-97.3pp
2022	+174.31%	+174.31%	—	-19.95%	+194.3pp

TPST underperformed the S&P 500 by 101.04pp over the past year (-69.72% vs +31.32%).

Loading summary...

TPST Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
TPSTTempest Therapeutics, Inc.	$56M	+27.0%	-31.5%	-69.7%	—	-92.4%	-87.9%	-99.9%
IMVTImmunovant, Inc.	$5.8B	+15.2%	+10.7%	+107.2%	—	+48.4%	+73.9%	+188.1%
AGENAgenus Inc.	$137M	+3.2%	+20.4%	+31.0%	—	-87.8%	-93.1%	-93.5%
AGIOAgios Pharmaceuticals, Inc.	$1.6B	-22.5%	-0.7%	-4.7%	—	+6.2%	-51.0%	-38.1%
RCUSArcus Biosciences, Inc.	$2.6B	+16.9%	+11.6%	+220.2%	—	+31.0%	-13.7%	+52.9%
NKTRNektar Therapeutics	$1.7B	+13.9%	+96.0%	+783.6%	—	+636.7%	-69.4%	-57.6%
FATEFate Therapeutics, Inc.	$264M	+92.4%	+131.3%	+139.1%	—	-58.0%	-97.0%	+33.9%
MGNXMacroGenics, Inc.	$191M	-5.3%	+87.0%	+104.8%	—	-58.4%	-90.6%	-83.4%
CRISCuris, Inc.	$81M	+15.7%	-37.1%	-71.8%	—	-96.1%	-99.7%	-99.7%
RVMDRevolution Medicines, Inc.	$32.1B	+58.2%	+91.2%	+303.5%	—	+518.1%	+420.9%	+422.7%
MRKMerck & Co., Inc.	$280.5B	-6.1%	+7.5%	+47.9%	+4.2pp	+3.9%	+73.3%	+171.4%

Compare:TPST vs IMVT TPST vs AGEN TPST vs AGIO TPST vs IMVT vs AGEN

About TPST Dividend Returns

Tempest Therapeutics, Inc. (TPST) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of TPST over the past year?

Tempest Therapeutics, Inc. (TPST) delivered a return of -69.72% over the past year. Since TPST does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in TPST be worth today?

A $10,000 investment in Tempest Therapeutics, Inc. one year ago would be worth $3,028 today, representing a loss of $6,972.

Q3Does TPST pay dividends?

Tempest Therapeutics, Inc. (TPST) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For TPST, the total return equals the price-only return.

Q4Did TPST beat the S&P 500?

No, Tempest Therapeutics, Inc. (TPST) underperformed the S&P 500 by 101.04 percentage points over the past year. TPST delivered a total return of -69.72%, compared to the S&P 500's 31.32%. This means a passive S&P 500 index fund outperformed TPST by 101.04pp during this period.

Q5What is TPST's worst drawdown?

Tempest Therapeutics, Inc. (TPST) experienced a maximum drawdown of -87.15% over the past year, declining from its peak on 2025-10-14 to its trough on 2026-03-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is TPST's long-term total return over 10, 20, or 30 years?

Here are Tempest Therapeutics, Inc. (TPST)'s long-term returns with dividends reinvested. Over 10 years, the total return is -99.9% (-47.9% CAGR) — $10,000 would have grown to $15. Over 20 years: -99.9% total return (-28.6% CAGR) — $10,000 → $12. Over 30 years: -99.9% total return (-20.1% CAGR) — $10,000 → $12. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was TPST's best and worst year?

Tempest Therapeutics, Inc.'s best calendar year was 2014 with a total return of 385.4%. Its worst year was 2016 with a total return of -83.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 468.8 percentage points.